Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01102998 · ClinicalTrials.gov registry record

Assessment of Sleep Complaints in Brain Tumor Survivors

A clinical trial, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
153
Enrollment target

NCT01102998 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 153 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01102998 has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
153 participants
Enrollment target

Study Summary

Survivors of pediatric brain tumors are noted to have increased rates of excessive daytime sleepiness. However, very little data are available regarding the specific sleep disturbances of pediatric brain tumor survivors. Children ages 8 to 18 years of age who are at least 5 years from diagnosis and at least 2 years post treatment or observation only for a brain tumor will be targeted to assess the prevalence of sleep complaints. The study focuses on the following objectives: * To estimate sleep disturbance in a cohort of pediatric brain tumor survivors. * Estimate the rates of parent- and self-reported excessive daytime sleepiness in pediatric brain tumors * Estimate the rates of parent-reported sleep-disordered breathing, including snoring and witnessed apneas, in pediatric brain tumor survivors * Estimate the rates of parent- and self-reported behavioral sleep problems, including nocturnal enuresis, bedtime resistance, nighttime awakenings, nightmares, and fatigue in pediatric brain tumor survivors. The Study focuses on the following secondary objectives: * To describe bedtime patterns and sleep hygiene of pediatric brain tumor survivors. * Estimate the typical parent- and self-reported weekday sleep duration of pediatric brain tumor survivors * Estimate the typical parent- and self-reported weekend sleep duration of pediatric brain tumor survivors and if it differs from the weekday sleep duration * Estimate the typical parent- and self-reported consistency of sleep hygiene in pediatric brain tumor survivors

Trial Details

FieldValue
Enrollment Target 153 participants
Start Date 2010-04
Est. Completion 2013-04

What the Registry Record Tells You About NCT01102998

The ClinicalTrials.gov registry entry for NCT01102998 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01102998 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01102998 about?

NCT01102998 is a clinical study titled "Assessment of Sleep Complaints in Brain Tumor Survivors". Survivors of pediatric brain tumors are noted to have increased rates of excessive daytime sleepiness. However, very little data are available regarding the specific sleep disturbances of pediatric brain tumor survivors. Children ages 8 to 18 years of age who are at least 5 years from diagnosis and ...

What is the current status of trial NCT01102998?

This trial is currently completed. The enrollment target is 153 participants. The study started on 2010-04. Estimated completion is 2013-04.

Who is sponsoring clinical trial NCT01102998?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.